First, confirm it is a true plateau, at least three weeks of no downward trend in the weekly average, rather than normal fluctuation
It is not medical advice, not a prescription, and not a recommendation for personal use
"Any future switch would come down to how well your current treatment is working for you, how well you tolerate it, and whether a different format genuinely makes it easier to stay on track long term, rather than preference alone. Aniyah Mansuri , weight loss expert at myBMI Sources Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial (2025)
Some compounding pharmacies send vials with incomplete labeling
This date is determined based on stability studies, compounding conditions, and regulatory guidelines
Previous studies suggested that patients with T2D typically experience lower %WL with GLP-1RAs, including semaglutide 2.4 mg compared with those with normoglycemia 22